Cargando…
Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
Ovarian cancer (OVCA) arises from three cellular origins, namely surface epithelial cells, germ cells, and stromal cells. More than 85% of OVCAs are EOCs (epithelial ovarian carcinomas), which are the most lethal gynecological malignancies. Cancer stem/progenitor cells (CSPCs) are considered to be c...
Autores principales: | Chung, Wei-Min, Chen, Lumin, Chang, Wei-Chun, Su, Sheng-Yuan, Hung, Yao-Ching, Ma, Wen-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304547/ https://www.ncbi.nlm.nih.gov/pubmed/34299364 http://dx.doi.org/10.3390/ijms22147748 |
Ejemplares similares
-
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
por: Chung, Wei-Min, et al.
Publicado: (2019) -
Short androgen receptor poly‐glutamine‐promoted endometrial cancer is associated with benzo[a]pyrene‐mediated aryl hydrocarbon receptor activation
por: Chen, Lumin, et al.
Publicado: (2017) -
The Role of Androgen Receptor Signaling in Ovarian Cancer
por: Mizushima, Taichi, et al.
Publicado: (2019) -
Minoxidil may suppress androgen receptor-related functions
por: Hsu, Cheng-Lung, et al.
Publicado: (2014) -
Therapeutic androgen receptor ligands
por: Allan, George F., et al.
Publicado: (2003)